SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bob zagorin who wrote (536)8/20/1997 3:13:00 PM
From: Andrew H   of 2173
 
If Murphy recommends it, then stay away! His record with biotechs is less than stellar! As you know.

AMLN may have other products very early in the pipeline, but for all intents and purposes for the Street, AMLN is indeed a one trick pony. And right now there is a big question how well the pony can perform that trick.

Still, it is getting pretty cheap here. But the Street can smash bios that have disappointed them. Shall we mention some other Murphy picks like CYTO COCN SQNA and CYTL?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News